Francesco Curra
Director Técnico/Científico/I+D en Cerevast Medical, Inc. .
Perfil
Francesco Curra founded Novuson Surgical, Inc. in 2014, where he worked as Director & Chief Technology Officer from 2014 to 2017.
Dr. Curra also currently works at Cerevast Medical, Inc., as Chief Technology Officer from 2018 and Longevity Biomedical, Inc., as Chief Technology Officer.
Dr. Curra received his doctorate degree from the University of Washington and undergraduate degree from Syracuse University.
Cargos activos de Francesco Curra
| Empresas | Cargo | Inicio |
|---|---|---|
Cerevast Medical, Inc.
 Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Director Técnico/Científico/I+D | 01/04/2018 |
Antiguos cargos conocidos de Francesco Curra.
| Empresas | Cargo | Fin |
|---|---|---|
Novuson Surgical, Inc.
 Novuson Surgical, Inc. Medical SpecialtiesHealth Technology Novuson Surgical, Inc. manufactures surgical devices. It develops a hemostatic platform technology for ablating tissue, isolating tumors, and providing hemostatic control prior to and during surgery. The company was founded by Stuart B. Mitchell in February 2014 and is headquartered in Bothell, WA. | Fundador | 01/08/2017 |
Formación de Francesco Curra.
| Syracuse University | Undergraduate Degree |
| University of Washington | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Cerevast Medical, Inc.
Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA. | Finance |
Novuson Surgical, Inc.
Novuson Surgical, Inc. Medical SpecialtiesHealth Technology Novuson Surgical, Inc. manufactures surgical devices. It develops a hemostatic platform technology for ablating tissue, isolating tumors, and providing hemostatic control prior to and during surgery. The company was founded by Stuart B. Mitchell in February 2014 and is headquartered in Bothell, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Francesco Curra
